Company Performance Metrics
- Eva Avrina: CEO, Co-Founder
NovaLaka is a technological innovator of slow release drug delivery systems in the drug delivery market focused on the transmucosal route and specialising in female healthcare.
The idea behind the technology arose from the glaucoma research supervised by NovaLaka's cofounders at the Jerusalem College of Engineering in Israel. NovaLaka
participated in round two of AtoBe's accelerator. Subsequently supported by the Israel Innovation Authority, NovaLaka now cooperates with numerous institutions including Hadassah Hospital.
We have developed an easy to apply smart polymeric substance, that is applied directly to the skin, in the treatment of vaginal dryness.
Our easy-to-adminster biofilm is applied directly to the affected area and provides immediate and prolonged release of our moisturising gel.
NovaLaka's innovation and development provides additional exciting opportunities in transmucosal and transdermal routes for drug delivery.
